Cagrilintide/semaglutide
A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Combined Versus Separate Injections in People With Overweight or Obesity
Novo Nordisk · Phase 1 · Completed · Enrollment 40
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Part A: Cagrilintide and semaglutide in separate syringes | Obesity or overweight | n/r | 14 | n/r | n/r |
| Part A: Cagrilintide and semaglutide combined in DV3384 device | Obesity or overweight | n/r | 14 | n/r | n/r |
| Part B: Cagrilintide and semaglutide combined in DV3384 device | Obesity or overweight | n/r | 14 | n/r | n/r |